ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01540409
Recruitment Status : Active, not recruiting
First Posted : February 28, 2012
Last Update Posted : November 25, 2016
Sponsor:
Information provided by (Responsible Party):
Sarepta Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : April 2016
  Estimated Study Completion Date : February 2017